The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...
The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher (CNPV) programme, a fast track for medicines that could deliver a decision on ...
Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...
A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results